Navigate Fool.com
Will JAZZ beat
the market?
Community Rating: 3 Stars: Appealing

146.21 3.92 (2.75%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $142.07
Previous Close $142.29
Daily Range $140.00 - $147.36
52-Week Range $70.41 - $176.60
Market Cap $8.7B
P/E Ratio 116.63
Dividend (Yield) $0.00 (0.0%)
Volume 823,306
Average Daily Volume 825,184
Current FY EPS $7.39

How do you think JAZZ
will perform against the market?

Top JAZZ Bull/Bear Pitches


grankh (< 20)
Submitted October 21, 2013

Another stock I own personally. Sales have grown 80% per year on average since 2010. EPS has grown 56% over the past 18 months. The profit margin has fluctuated considerably, so not joy there. The … More

0 Replies Reply Report this Post

ross812 (< 20)
Submitted March 5, 2010

Garbage. Garbage. Garbage!!! See what happens if they fail a drug trial!

0 Replies Reply Report this Post

News & Commentary Rss Feed

Of These 3 Battleground Biotech Stocks, 1 Is a Buy

Do Amarin, Prosensa, and Jazz Pharmaceuticals deserve a goal, a yellow card, or a straight stay-away red card?

iShares U.S. Pharmaceuticals ETF Experiences Big Outflow

The 3 Best Tax Havens for Health Care Companies

As health-care multinational corporations look to cut costs, companies in these three tax havens could be ripe takeover targets.

Is This Jazz Pharmaceuticals' Worst Nightmare?

Shares of orphan drugmaker Jazz Pharmaceuticals have more than doubled in the last year, propelled by growing sales of its narcolepsy drug Xyrem. But a hidden danger may derail this growth stock in the near future.

Why Jazz Pharmaceuticals Is an Attractive Buyout Candidate

Despite a high volume of European acquisitions Jazz Pharmaceuticals is yet to join the party, but why not, and will it ever?

Tuesday's ETF Movers: GDXJ, XPH

See Which Stocks This $23 Billion Winner Bought

Might you want to buy any of them yourself?

Takeover Stocks: Screening For Value, Cash Flow

The Dangers of Chasing Hopeful Merger and Buyout Stocks

First Week of JAZZ July 19th Options Trading

See More JAZZ News...





Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website: http://www.jazzpharma.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks